It is already known that decitabine demethylates tumor-suppressor genes such as p15INK4b, E-cadherin and MYOD1 [50,51], making it efficacious in treating various malignancies in which these genes play a crucial role. The gene discussed is CDKN2B; the disease is neoplasm.